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Abstract  
Electrospinning forms fibers from either an electrically charged polymer solution or polymer melt. 
Over the past decades it has become a simple and versatile method for nanofibers production. Hence 
it has been explored in many different applications. Commonly used electrospinning assembles 
fibers from polymer solutions in various solvents, known as solution electrospinning. While melt 
and near-field electrospinning techniques enhance the versatility of electrospinning. Adaption of 
additive manufacturing strategy to electrospinning permits precise fiber deposition and predefining 
patterns construction. This manuscript critically presents the potential of electrospun nanofibers in 
healthcare applications. Research community drew impetus from the similarity of electrospun 
nanofibers to the morphology and mechanical properties of fibrous extracellular matrices, ECM of 
natural human tissues. Electrospun nanofibrous scaffolds act as ECM analogs for specific tissue 
cells, stem cells and tumor cells to realize tissue regeneration, stem cell differentiation and in vitro 
tumor model construction. The large surface-to-volume ratio of electrospun nanofibers offers a 
considerable number of bioactive agents binding sites, which makes it a promising candidate for a 
number of biomedical applications. The applications of electrospinning in regenerative medicine, 
tissue engineering, controlled drug delivery, biosensors and cancer diagnosis are elaborated. 
Electrospun nanofibers incorporations in medical device coating, in vitro 3D cancer model and 
filtration membrane are also discussed.  
Introduction 
As reported by “Research and Markets”, the global market for nanofibers can reach 1 billion U.S. 
dollars by the end of 20211. Electrospinning is a simple and versatile process to fabricate micrometer 
and nanometer scale thickness fibers that contributes to the emerging nanotechnology field. In 
simple terms, the electrospinning process relies on an electrohydrodynamic principle that a highly 
electrified polymer solution or melt is forced to stretch and elongate into fibers (Figure 1A). 
Electrospraying involves applying high voltage to liquid jets as well, whereas particles are collected 
instead of fibers (Figure 1B).  
In solution electrospinning where a polymer solution is elongated and thinned by whipping effect, 
quick evaporation of solvents results in solidification of the polymer jet and nanofibers deposition. 
Whereas in melt electrospinning (Figure 1C), polymers remain a molten state that exhibit lower 
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electrical conductivity, higher viscosity and lower density of surface charge than polymer solutions. 
The solidification of molten jets relies on heat transfer between the jet and surrounding medium. 
Such rapid solidification further suppresses the whipping effect and requires stronger electrostatic 
repulsion to overcome the viscoelastic force2. Therefore, the electrostatic force mainly contributes 
to thinning of the molten jet, which is not as sufficient as solution electrospinning with whipping 
effect and solvent evaporation. The diameter of melt electrospun fibers is typically on the 
micrometer scale, while the jet travels in a straight path before deposition and solidification allowing 
better fiber placement control. Since a heating device is included in melt electrospinning set-up, 
thermoset polymers, thermally unstable polymers and some bioactive molecules cannot be 
incorporated. The conventional electrospinning is usually conducted in the far-field model where 
the distance between the spinneret and collector ranges in 5-15 cm with a high applied voltage (10-
20 kV)2. By reducing that distance to 500 μm - 1 cm2,3, near-field electrospinning can be obtained 
(Figure 1D). The electric field will be highly concentrated within such short distance that permits 
substantially reduced applied voltage to several hundred volts (normally 0.6-3 kV3). The whipping 
instability is dampened in near-field electrospinning, and the jet is deposited on the collector within 
straight segments. Similarly, like melt electrospinning, near-field electrospinning allows precisely 
spatial control of fiber deposition together with fiber diameters on micrometer scale. Yet with lower 
applied voltage, near-field electrospinning is more suitable than melt electrospinning for bioactive 
molecules accommodation.  
Recently, researchers have adopted additive manufacturing (AM) concept to electrospinning for 
more accurate control of fiber deposition4–6. AM enables fabrication of 3D constructs with 
customized geometry and structure, whereas the spatial resolution is quite limited. Direct write 
electrospinning (Figure 1E) is an integration of electrospinning and AM that combines the 
nanofibrous characteristics of electrospinning and accurate designing potential of AM. In direct 
write electrospinning, the jet is focused to travel in a straight line via auxiliary electrodes, melt 
electrospinning or near-field electrospinning. Together with predefining translational movement of 
the collector, 3D constructs with designed patterns and accurately controlled features such as pore 
size7 can be produced.  
Initial applications of electrospinning emerged in air filtration and personal protection purposes. 
Subsequently, efforts are made for diverse applications in medicine and healthcare, water treatment, 
damage resistant composites, light weight buildings and construction, mitigation of noise pollution, 
energy generation and storage, photonics, electronics and wearables. This paper focuses on 
medicine and healthcare applications.   
Bioengineering and biomedical engineering research community drew impetus from the similarity 
of electrospun nanofibers to the morphology and mechanical properties of fibrous extracellular 
matrices, extracellular matrix (ECM) of natural human tissues (Table 1 (Refs. 2, 8 and 9 )). ECM is 
a collection of extracellular molecules secreted by cells that provide mechanical support and 
biochemical cues to surrounding cells and tissue2. It is a complex and heterogeneous network with 
tissue-specific characteristics. The highly porous structure of ECM allows nutrients and oxygen 
diffusion and transport. Adequate pore size is critical to support cell-cell and cell-matrix interactions. 
Collagen is the most abundant fibrous protein in native ECM, which offers structural support and 
topographic guidance through specific orientations to surrounding cells and facilitate cell-cell 
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interactions. Collagen exists as nanofibers with a diameter of 50-500 nm and accounts for the 
nanofibrous structure of ECM with specific fiber alignment. Biomolecules residing in the ECM 
provide intrinsic biochemical cues in regulating cellular functions as well as cell-matrix interaction. 
Mechanical properties such as stiffness of the ECM can affect cellular activities including adhesion, 
migration, proliferation and differentiation. For example, neural stem cells cultured on stiffer matrix 
(1-10 kPa) showed glial differentiation, while exhibited neural differentiation on softer matrix (100-
500 Pa)10. Similarly, electrospun nanofibers can assemble into a nanofibrous network with tailorable 
porosity and pore size. The diameter of nanofiber can be altered accordingly as well. Through 
various electrospinning set-up such as different collectors design, the fiber orientation can be 
customized. Electrospinning of various materials blends leads to optimal mechanical properties of 
electrospun fibers that maintain the integrity and match with native ECM.  
Table 1. Similarities between electrospun fibers and fibrous ECM. 
Characteristics Natural ECM Electrospun fibers 
Diameter of fibrous 
components 
50-500 nm (collagen fibers2) Tens to hundreds of 
nanometers 
Porosity & pore size Highly interconnected pores 
Tissue-specific 
E.g.8 Neovascularization: 5 μm 
Fibroblast ingrowth: 5-15 μm 
Bone regeneration: 200-350 μm 
Skin regeneration: 20-125 μm 
Highly porous 
Interconnected pores 
Tailorable 
Mechanical properties Tissue-specific 
E.g.9 Cancellous bone:  
0.4 GPa (modulus); 7.4 MPa (tensile strength) 
Articular cartilage:  
10.5 MPa (modulus); 27.5 MPa (tensile strength) 
Skin:  
0.1- 0.2 MPa (modulus); 7.6 MPa (tensile strength) 
Tailorable 
Vary across materials 
selection, porosity 
control and fiber 
orientation 
Physical architecture Tissue-specific 
E.g. Skin: basketweave-like pattern of collagen fibers 
Tendon: parallelly aligned collagen fibers 
Tailorable 
 
Nanofibers with relatively large surface-to-volume ratio, and nanofibrous structure with high 
porosity make electrospun products potential for tissue engineering and regenerative medicine, drug 
delivery, biosensors, diagnostics, and etc. (Figure 2). The first patented electrospun product in 
biomedical applications is a wound dressing mat by Martin et al. in 197711. Since then, 
electrospinning has been widely explored for healthcare applications especially over the past two 
decades (Figure 3). Herein this review, we described recent advances related to biomedical 
applications of electrospinning through representative examples. We mainly focus on electrospun 
nanofibers in tissue engineering and regenerative medicine, drug delivery, biosensors and cancer 
diagnosis. Other applications including medical device coating, in vitro 3D cancer models, viral and 
microbial resistant surgical masks, respirators, and personal protective equipment, as well as 
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filtration membranes related to the coronavirus disease 2019 (COVID-19) outbreak are discussed 
as well. Current challenges in each application are mentioned along with future perspectives.  
 
Figure 1. Schematic illustrations of (A) electrospinning and (B) electrospraying. The charged jet can be 
kept in a continuous form to produce fibers in electrospinning, whereas it breaks into droplets to form 
particles in electrospraying. During electrospinning, the ejected jet initially follows a straight line in the 
near-field zone, and undergoes stretching and thinning upon whipping motions in the far-field zone. (C) 
Schematic illustration of melt electrospinning. Unlike conventional solution electrospinning, a heating 
device is attached to maintain a molten jet in melt electrospinning. Normally, the jet travels in a straight 
line and generates micrometer scale fibers. (D) Schematic illustration of near-field electrospinning. The 
jet deposited on the collector within the straight segment, which shows higher spatial control of fiber 
placement but larger fiber diameter. (E) Schematic illustration of direct write electrospinning that 
integrates AM concept to electrospinning. A translational collector is used for predefined pattern 
construction.  
 
Figure 2. Applications of electrospinning in healthcare.  
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Figure 3. Development of electrospinning in biomedical applications. Electrospun nanofibers have been utilized in biomedical applications mainly as wound dressing 
and implant coating since 1977. There were broad applications of electrospinning in healthcare in past two decades. From 2000 to 2020, key applications of 
electrospinning in healthcare are summarized and presented at 5-year intervals. From 2020 to 2030, two future trends of applying electrospinning in healthcare are 
suggested with examples. CNS implant: central nervous system implant. 
 
T
hi
s 
is
 th
e 
au
th
or
’s
 p
ee
r 
re
vi
ew
ed
, a
cc
ep
te
d 
m
an
us
cr
ip
t. 
H
ow
ev
er
, t
he
 o
nl
in
e 
ve
rs
io
n 
of
 r
ec
or
d 
w
ill
 b
e 
di
ffe
re
nt
 fr
om
 th
is
 v
er
si
on
 o
nc
e 
it 
ha
s 
be
en
 c
op
ye
di
te
d 
an
d 
ty
pe
se
t.
P
L
E
A
S
E
 C
IT
E
 T
H
IS
 A
R
T
IC
L
E
 A
S
 D
O
I:
 1
0
.1
0
6
3
/5
.0
0
1
2
3
0
9
 6 
 
Tissue engineering and regenerative medicine 
Tissue engineering as first fully illustrated by Langer and Vacanti12, is a highly multidisciplinary 
field for damaged tissue regeneration that accommodates cells into porous scaffolds made of 
biomaterials and guide their growth to new tissue13,14 (Figure 4). Electrospinning has been widely 
explored for nanofibrous scaffolds fabrication and achieve promising replication of native ECM in 
terms of composition and architecture. Whereas the composition and structure of ECM are tissue 
specific leading to specific requirements in different applications15. Applications of conventional 
electrospun scaffolds in tissue engineering are limited in mechanical incompliance between 
scaffolds and native ECM such as in bone and cardiac regeneration, inefficient replication of  
complex and anisotropic structure such as in tendon, cartilage and tissue-to-tissue interface, and 
difficulty in providing specific functionality such as electrochemical stimulation to neural and 
cardiac tissue, anti-thrombogenicity of vascular grafts and scar inhibition in skin regeneration.  
Recent electrospun scaffolds in tissue engineering and regenerative medicine could combine various 
guidance to address aforementioned problems via a synergistic effect on stem cell differentiation 
(Table 2 (Refs. 6 and 16–34)) and tissue regeneration. Basically, topographical and biomechanical 
cues can be generated via scaffold design and configurations, biological cues can be accomplished 
by bioactive agents and/or biomolecules incorporation and electrochemical cues are attained 
through material selection, fiber chemistry, thickness and porosity control as needed. Fibrous 
proteins assemble a 3D network in ECM with specific fiber orientation varying across tissues. 
Compared to conventional 2D electrospun scaffolds, 3D scaffolds are favored in resembling natural 
ECM. Electrospinning in specific tissue engineering applications as the potential solution to current 
limitations is discussed in the following section.  
 
Figure 4. Basic concept of tissue engineering approach for tissue regeneration. (A) Tissue engineering is 
a highly multidisciplinary field that recruits experts from engineering, materials science, life science and 
clinical medicine. (B) In tissue engineering, biocompatible scaffolds act as a temporary template for 
tissue-specific cells growth and proliferation, and are occasionally incorporated with biomolecules for 
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enhanced cell regulation and tissue regeneration. Upon implantation of the engineered tissue, scaffolds 
will gradually degrade leaving regenerated tissues or organs with restored functionality.  
Table 2. Examples of electrospinning for stem cell differentiation. 
Electrospun scaffolds features Stem cell types Stem cell differentiation 
Topographical & mechanical cues 
Uniaxially aligned 
nanofibers16,17,27 
Adipose derived MSCs 
iPSCs derived MSCs Tenogenic differentiation 
Human fetal osteoblasts Osteogenic differentiation 
Bone marrow derived MSCs Neural differentiation 
Uniaxially aligned yarns28 Adipose derived MSCs Anisotropic soft tissue differentiation 
Orthogonal layers29 Bone marrow derived MSCs Osteoblastic differentiation 
Coiled nanofibers30 Bone marrow derived MSCs Mild myofibroblastic differentiation 
Honeycomb-compartmented 
monolayer31 iPSCs Cardiac differentiation 
Netslike nanofibrous mesh32 Bone mesenchymal stromal cells Osteogenic differentiation 
Zonal organized nanofibers6 Mesenchymal stromal cells Chondrogenic differentiation 
Higher degree of roughness 
Lower degree of roughness33,34 Mesenchymal stromal cells 
Osteogenic differentiation 
Chondrogenic differentiation 
Lower stiffness18 Smooth muscle cells Contractile phenotype 
Dynamic mechanical 
stimulation19 Adipose derived MSCs Tenogenic differentiation 
Electrochemical cues 
Electrical pulse application20 Cardiovascular disease specific iPSCs Cardiomyocytes 
Piezoelectric scaffold21 Bone marrow derived MSCs 
Osteogenic differentiation (high 
voltage) 
Chondrogenic differentiation 
(low voltage) 
Biological cues 
Hemin doping22 iPSCs derived neural stem cells Neural differentiation 
Retinoic acid induction23 Chorion derived MSCs Neural differentiation 
Peptide decoration 24 Human PSCs Osteogenic differentiation 
BMP-2 peptide25 Adipose derived MSCs Osteogenic differentiation 
Co-culture with chondrocytes26 Bone marrow derived MSCs Chondrogenic differentiation 
MSCs: mesenchymal stem cells; iPSCs: induced pluripotent stem cells; BMP-2 peptide: bone 
morphogenic protein-2 
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Electrospinning in bone regeneration 
Mechanical properties incompliance between electrospun scaffolds and native bones is a common 
problem. Polymers are the most commonly electrospun materials, yet exhibit lower modulus than 
native hard tissue in general9. The ideal scaffold should offer sufficient mechanical support during 
bone regeneration and biochemical guidance to induce osteogenesis for healing acceleration. A 
sponge-like 3D nanofibrous silk fibroin/PCL scaffold was mineralized and immobilized with BMP-
2 peptide25. The mineralization improved the compressive modulus of scaffolds significantly (468.5 
± 48.7 kPa v.s 109.3 ± 21.8 kPa). However, such modulus is much lower than that of native 
cancellous bones of 0.4 GPa9. The authors suggested that those sponge-like scaffolds were potential 
to calvarial defects. Since the major contents in bone are type I collagen fibrils and hydroxyapatite 
nanoparticles. For bone regeneration, biocompatible and biodegradable polymeric scaffolds are 
always reinforced with inorganic substance such as hydroxyapatite, bioactive glass and silica. An 
electrospun scaffold out of silk fibroin/PVA/58S bioglass was developed for bone regeneration35. 
The addition of bioactive glass significantly improved the mechanical properties of scaffolds with 
a raised Young’s modulus from 293 ± 64 MPa to 655 ± 151 MPa. Considering relatively high 
modulus of ceramics and metals, incorporation of such stiffer materials into polymeric matrix or 
developing polymer-free ceramic scaffolds for hard tissue regeneration is expected.  
Electrospinning in cartilage regeneration 
Unlike bone, the major components in cartilage is type II collagen and proteoglycan. There is a 
zonal organization and distribution of collagen in cartilaginous ECM that the content decreases from 
the superficial zone to the deep zone. Collagen fibrils are aligned parallel to the articular surface in 
the superficial zone, while oriented perpendicular to the articular surface in the middle and deep 
zones. For 2D planar mats, the ongoing challenge is to achieve fully cell infiltration through the 
defects. A 3D nanofibrous scaffold with hierarchical architecture, sufficient compressive strength 
and highly interconnected pores is more ideal. Chen et al. combined direct writing with solution 
electrospinning for hierarchical scaffolds fabrication mimicking the zonal organization of articular 
cartilage6. The 3D multiscale fibrous scaffolds promoted chondrogenic differentiation of hMSCs 
and directed tissue organization in a zone-dependent way.  
Electrospinning in tendon and ligament regeneration 
Collagen fibers are closely packed in parallel arrays in tendon and ligament. Thus, uniaxially aligned 
nanofibrous mats are widely applied to tendon and ligament regeneration. Uniaxial aligned 
nanofibers can be easily collected using a rotating collector or extra parallel electrodes. Adipose 
derived MSCs and iPSC derived MSCs show tenogenic differentiation on uniaxial nanofibers. 
However, the bulk of tendon and ligament tissue present highly anisotropic structures. 3D scaffolds 
with braided, woven or knitted yarn networks are more favored instead of 2D mats. When including 
hydrogels into the nanofibrous matrix, it can benefit biomolecules and cells encapsulation. For 
example, unidirectional PCL nanofibers were once coated with chitosan/hyaluronic acid hydrogel 
for ligament regeneration36.  
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Electrospinning in tissue-to-tissue interface regeneration 
Currently, regeneration of tissue-to-tissue interface remains challenging. Those interfaces 
containing soft-to-hard interfaces and soft-to-soft interfaces. In the junctions between a soft matrix 
and a hard matrix (e.g. tendon/ligament-to-bone, cartilage-to-bone), there are gradual variations in 
matrix composition, architecture, mineral content and significant difference in mechanical 
properties37. An ideal scaffold should contain a hierarchical structure that allows a transmission in 
structure and mechanical stress between two mechanically differed tissues. Spatially organized 
nanofiber structure, materials composition with graded distribution and bioactive agents can 
attribute to a specialized scaffold for regeneration of such interfaces. A nanofibrous mat with 
“aligned-to-random” nanofibers was developed to mimic the graded structure in tendon-to-bone 
interface38. The aligned nanofibers represented highly aligned collagen fibers n tendon, while 
random portion mimicked the less ordered collagen fibers in bone. A dual-layer organic/inorganic 
nanofibrous scaffold was fabricated to recapitulate the gradient mineral content within tendon-to-
bone interface39. The PLLA/nanohydroxyapatite (nHA) nanofibrous mat was synthesized via 
electrospinning of nHA on the top of PLLA electrospun mat, which resembled the mineralized and 
non-mineralized fibrocartilage in the interface, respectively. For cartilage-to-bone interface 
regeneration, nanofibrous scaffolds are always combined with hydrogels since cartilage is a resilient 
tissue. Mohan et al. designed a 3D hybrid scaffold that assembled PCL nanofibers with gradients of 
chondroitin sulfate and bioactive glass into hydrogel40. The chondroitin sulfate addition promoted 
glycosaminoglycan-enriched ECM secretion by chondrocytes mimicking the hyaline cartilage, 
whereas the bioactive glass content enhanced mineralized ECM formation.  
Muscle-to-tendon interface and interface at the neuromuscular junction are two typical soft-to-soft 
tissue interfaces. The myotendinous junction connects dense collagen fibers in tendon to softer 
muscle fibers. The main difficulty in regeneration of myotendinous junction is a comparable 
stiffness transition to native junctions. For example, Ladd et al. developed PCL/PLA nanofibrous 
scaffolds followed the mechanical trend to native myotendinous junctions41. However, the ratio of 
tendon to muscle stiffness was 6, which is far from the natural ratio in the range of 179-3700042. 
Studies on neuromuscular junction remodeling are quite limited. Natural neuromuscular junction is 
essential to support native functionality of motor neurons and skeletal muscles. The scaffolds should 
recapitulate the innervation in living skeletal muscles and restore the response of muscles to 
neurotransmitters42. Culturing stem cells on the scaffolds and guiding them into desired 
differentiation such as tenogenic, myofibroblastic and neural differentiation may help with the 
interface reconstruction. 
Electrospinning in cardiac regeneration 
It is critical to maintain sufficient mechanical strength in cardiac tissue to sustain myocardium 
contraction and relaxation. The perimysial fibers in myocardium exhibit a coiled structure and 
compose an interwoven feature of myocardium. Complete replication of such anisotropic 
organization and mechanical capability of cardiac tissue remains challenging. Liu et al. developed 
honeycomb-patterned scaffolds for better mimicking the myocardium architecture43. The beating 
rate of cardiomyocytes on patterned scaffold showed a comparable value to adult or neonatal rats. 
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One study investigated coiled PCL nanofibers together with gold nanoparticles to restore the 
myocardium functionality44. Those scaffolds design is mainly focusing on planar scaffolds, which 
has limited effect on myocardium maturation45. A 3D scaffold that replicate the architecture, the 
mechanical properties and the native function of cardiac tissue is highly desired in the future. Since 
the heart wall is a multi-layered structure, scaffolds composing multilayers or a yarn network are 
suggested for more efficient tissue regeneration2. Each layer can be individually controlled over the 
nanofiber orientation and layer pattern. Thus, the interwoven and anisotropic structure of native 
cardiac tissue can be better emulated. To further restore the functionality of the myocardium, 3D 
electrospun scaffolds integrated with electrochemical cues are favored. Wang et al. developed a 3D 
bioactuator in a tubular shape by loading cardiomyocytes on conductive PLA/PANi nanofibers, 
which combined topographic, biological and electrochemical cues together46. Cardiomyocytes on 
such 3D scaffolds showed higher beating frequency than those cultured on planar scaffolds. 
Electrospinning in neural regeneration 
Both uniaxially and radially aligned nanofibers have been demonstrated to be effective in neural 
regeneration. Bone marrow derived MSCs can differentiate into Schwann cells on uniaxially 
oriented PCL nanofibers27. Radially aligned nanofibers are attractive for spinal cord injury repair, 
which recruits cells from central canal region to lesion site. Li et al. developed radially aligned 
electrospun collagen/PCL mats with a circular gradient of biomolecules incorporation47. Such 
scaffolds directed and promoted neural stem cells migrated from periphery to center along 
nanofibers. However, planar scaffolds are mainly used in in vitro neural tissue regeneration studies. 
A nerve guidance conduit (NGC) with a complex, multitubular structure is widely used in in vivo 
studies. Currently, including all the topographic and biochemical characteristics of native nerve 
tissue in NGC design remains challenging. The size of intraluminal microchannels in NGC can be 
controlled via sacrificial templates such as sucrose fibers48. With controllable channel, intraluminal 
fillers can be introduced to obtain additional topographical cues. PLGA unidirectionally aligned 
nanofibers with laminin coating have been used as fillers within NGC, which provides topographic 
and biological guidance to nerve tissue regeneration simultaneously49. Piezoelectric polymers and 
conductive polymers can provide electrical stimulation to cells. A conductive polypyrrole (PPy)/silk 
fibroin NGC was fabricated by 3D printing and electrospinning50. Unidirectional PPy/silk fibroin 
fibers were 3D printed as incorprated as intraluminal fillers. A dual-layer of electrospun aligned and 
random silk fibroin nanofibers assembled the shell of NGC. The topographic and electrical cues of 
such NGCs allowed proliferation of Schwann cells and in vivo axonal regeneration. Further study 
can focus on integrating biological, topographic and electrochemical cues in nanofibers for better 
neural regeneration due to the synergistic effect of those guidance.  
Electrospinning in vascular regeneration 
There are commercially available vascular grafts for large-size blood vessels regeneration, yet 
studies of regenerating blood vessels of small diameter (i.e., <6 mm) are quite limited. Unlike grafts 
for large-diameter arteries, the major concern for small-diameter vascular grafts is maintaining the 
lumen patency51. Graft occlusion typically occurs in small-size blood vessels due to acute 
thrombosis and intimal hyperplasia, which significantly impairs vascular grafts function. 
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Construction of a non-thrombogenic scaffold surface and achieving rapid endothelization within the 
electrospun scaffolds are both critical in avoiding thrombosis. There are limited research 
investigating scaffold surface configuration for anti-thrombosis. Current approaches are 
incorporation of biomolecules into nanofibers such as heparin for anticoagulation, and accelerating 
endothelization within the grafts. Surface modified with biomolecules (e.g. vascular endothelial 
growth factors) through covalent bonding or core-sheath structure to promote endothelial cells 
recruitment52, or local delivery of miRNA to modulate endothelial cell phenotype have been both 
investigated53. Other approaches rely on direct pre-seeding of endothelial cells or endothelial 
progenitor cells on electrospun grafts54. Maintaining a contractile phenotype of smooth muscle cells 
(SMCs) is critical in minimizing intimal hyperplasia. Highly aligned PCL/ hyaluronan nanofibers 
promoted higher contractile gene expression in SMCs55. It is worth noted that intimal hyperplasia 
occurs in all vascular grafts with different degrees due to blood flow profiles, which is independent 
of scaffold materials51. While compliance mismatch between the scaffolds and native vessels 
partially results in intimal hyperplasia. Developing a vascular graft to obtain mechanical properties 
consistent with native vessels is of great importance.  
Electrospinning in skin regeneration 
In native ECM, the fibrous structure always exhibits a more complex architecture other than simple 
unidirectional alignment. Collagen fibrils in skin tissue show a mesh-like or a basketweave-like 
pattern. Therefore, scaffolds with crossed nanofibers showed higher keratinocytes and fibroblasts 
migration rate thus better wound healing performance than either random or unidirectionally aligned 
nanofibers56. A highly porous cotton-wool-like PCL/chitosan scaffold was developed using 
emulsion electrospinning and achieved accelerated full-thickness wound healing in 3 weeks in 
vivo57. One major concern for wound healing is scar inhibition, which is a long-lasting obstacle in 
clinical studies. Abnormal fibroblast proliferation and subsequent collagen deposition lead to scar 
formation. Several cell signaling molecules including basic fibroblast growth factor (bFGF), 
transforming growth factor-β1 (TGF-β1) and ginsenoside-Rg3 have been studied to address it. 
Ginsenoside-Rg3 and bFGF can promote normal function of fibroblast, thus have been introduced 
to PLGA nanofibers by blend electrospinning and surface immobilization58. Whereas TGF-β1 
signaling would promote fibroblast abnormal proliferation. TGF-β1 inhibitors were loaded in 
PCL/gelatin nanofibers via blend electrospinning for hypertrophic scarring inhibition59. To prevent 
scar formation, effect of nanofibers on the cellular signaling mechanisms and biochemical pathways 
should be elucidated. Whether the nanofiber features such as fiber diameter and fiber alignment 
would influence the scar inhibition remains to be determined. 
Drug delivery and controlled release 
The principle of using polymer nanofibers as drug carriers is that the dissolution rate of drugs 
increases with the increase of surface area of both drugs and carriers60. The inherent higher surface-
to-volume ratio of electrospun nanofibers affords high drug loading capacity and efficiency. 
Electrospun nanofibers can achieve controlled drug release with better preserved bioavailability by 
different drug encapsulation design. Typical drug loading strategies include post-electrospinning 
modification, blend electrospinning, coaxial electrospinning and nanoparticles encapsulation 
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(Figure 5). Different drug loading strategies lead to different interactions between drugs and 
nanofibers that results in different drug releasing kinetics. Initial burst release typically occurs in 
drug loading avenues. Practically, initial release of specific drugs in clinic can benefit the anti-
inflammatory effect in early stage. It would be more favorable to secure controlled and sustained 
drug release in complex scenarios. The localized and target-specific delivery of anti-cancer drugs 
can further eliminate potential damage of chemotherapy to surrounding tissue. Potential strategies 
to achieve controlled drug release with preserved bioactivity are discussed in the following section. 
 
Figure 5. Common approaches of loading drugs into electrospun nanofibers. Post-electrospinning 
modifications including simple physical adsorption and surface immobilization for more controlled drug 
release. Blend electrospinning and coaxial electrospinning allow drug encapsulation to as-spun 
nanofibers. Loading drugs into particles follows by particles incorporation to nanofibers permit a more 
versatile drug delivery system by tailoring characteristics of both nanofibers and particles. Characteristics 
of each approach are presented. 
Physical adsorption is the simplest way to introduce drugs to the electrospun matrix, which is prone 
to an initial burst release and inefficient in sustained drug release61. Since the post-electrospinning 
concept can prevent bioactive agents from destabilization and denaturation during the 
electrospinning process, research on more controlled release with surface localized drugs is highly 
encouraged. One strategy is surface immobilization of drugs to nanofibers and by controlling the 
degradation rate of a specific conjugation linker to achieve controlled drugs release. For instance, it 
is reported that there is an inverse correlation between matrix-metalloproteinase (MMP) levels and 
diabetic ulcer wound healing rate62. A complex of linear PEI and DNA was conjugated to a 
PCL/PEG scaffold via an MMP cleavable peptide linker for diabetic ulcer healing63. Compared to 
direct immobilization of DNA to scaffolds, the modified conjugating system showed an MMP 
dependent release profile.   
Blend electrospinning and emulsion electrospinning of bioactive drugs and polymers are two typical 
strategies to incorporate drugs in as-spun nanofibers. Electrospinning of drug and polymer blends 
with a hand-hold device allows for direct deposition of drug loaded fibrous matrix to the wound site. 
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However, one thing worth noted is that the addition of drugs could affect the properties of 
electrospinning solution such as solution conductivity and viscosity. When loading meloxicam in 
PVA solutions, the solution viscosity was elevated and in turn resulted in thicker fibers as reported64. 
Besides, improving the drug-polymer compatibility is worth considered for more controlled drug 
release. Otherwise, drugs tend to accumulate on the surface of nanofibers leading to a burst release65. 
Zeng et al. investigated different release kinetics between doxorubicin base and doxorubicin HCl in 
electrospun PLLA nanofibers66. Results revealed that a 70% burst release of doxorubicin HCl due 
to a rapid wash-off from the nanofiber surface where it accumulated on. In contrast, doxorubicin 
base only showed a 20% burst release since it embedded into the fibers other than residing on the 
surface. 
When processing drugs/polymer blends through electrospinning, how to preserve the bioactivity of 
drugs is another challenge. Drugs would be in direct contact with organic solvents, high electric 
charge and even mechanical stress during electrospinning. Therefore, the bioactivity of drugs, some 
labile molecules in particular, will be hindered. To stabilize the drugs, binding them to other 
molecules may be an option61. For example, emulsion electrospinning of BMP-2 and PLGA resulted 
in denaturation of BMP-267. When included hydroxyapatite into the formulation, the bioactivity of 
BMP-2 was retained. Similarly, using bovine serum albumin (BSA) as a stabilizer for 
electrospinning of NGFs and poly (caprolactone-co-ethylethylene phosphate) led to preserved 
bioactivity to some extent68. Blending drugs with polymers (e.g. silk fibroin) that can be electrospun 
under mild processing conditions can be another approach. Near-field electrospinning exhibits 
concentrated electric filed, thus allows for a substantially reduced applied voltage. That can be 
further investigated for drug delivery since it can minimize the electrically charged effect on 
bioactivity. Coaxial electrospinning of drugs and polymers provides a more sustained drug release. 
Normally, drugs are embedded in the core and released through either pores in the sheath or shell 
polymer degradation. Due to the barrier effect of the sheath structure, an initial burst release can be 
avoided. The shell polymer solution guarantees the successful fiber formation in coaxial 
electrospinning, and the electric charge is predominantly found on the sheath61. Therefore, core-
sheath nanofibers are preferred for delivery of labile molecules such as enzymes and growth factors 
even cells can be included69.  
One current research focus is to the construction of a “smart” drug delivery system for controlled 
release in terms of target-specific and triggerable. Incorporating drug loaded nanoparticles and 
microspheres into electrospun nanofibers is a common strategy for better control of drug release. 
The host fiber characteristics as well as the particle properties can be both tailored for specific 
requirements. The drug delivery system containing drugs encapsulated particles and electrospun 
nanofibers is highly desired in cancer therapeutics. Localized and controlled chemotherapy can be 
achieved with higher therapeutic efficiency but lower drugs dosage hence lower toxicity to 
surrounding tissue. A pH-sensitive anti-tumor drug delivery system was constructed by 
encapsulating CaCO3-capped mesoporous SiO2 nanoparticles in PLLA electrospun fibers70. 
Doxorubicin (DOX), an anti-tumor drug was loaded into nanoparticles. The reaction between 
CaCO3 and the acidic environment on the tumor site would stimulate the release of DOX. While in 
normal tissue with the physiological pH, only a minor release of such anti-tumor drug was detected. 
That pH-responsive anti-cancer efficacy can last over 40 days. Trametinib loaded hollow copper 
silicate was introduced to PCL/PDLLA electrospun matrix for chemo-photothermal therapy of 
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melanoma71. This anti-tumor drug delivery system was near-infrared irradiation (NIR)-sensitive. 
Releasing of multiple drugs attribute to a synergistic therapy that exhibits better antitumor efficacy. 
For example, co-delivery of paclitaxel and RNA interference (RNAi) to brain tumor simultaneously 
inhibited tumor angiogenesis and suppressed tumor cells proliferation72. The RNAi and drugs were 
loaded in PEI nanoparticles and then encapsulated into PLGA electrospun microfibers. Surface 
immobilized of nanofibers or particles with functional groups allow for higher tumor cells affinity, 
hence better target efficiency. In one demonstration, folate decorated PCL/PEG micelles were 
loaded with DOX and processed through coaxial electrospinning with PVA aqueous solution73. 
DOX contained micelles resided in the core, while PVA nanofiber composed the outer sheath. Folate 
can bind to folate receptors that usually overexpressed on a number of solid tumors, which 
constructs an active-targeting drug delivery system74.   
Biosensors and cancer diagnosis 
Biosensors are normally composed of biofunctional membranes and transducers for biological 
substances detection, where the sensing membrane is responsible for substances recognition, and 
transducer converts it into output signals75 (Figure 6). The sensing membrane affects the 
performance of a biosensor including sensitivity, selectivity, reproducibility and response time. High 
sensitivity is highly important in successful detection of biological substances at relatively low 
concentrations, to which electrospun nanofibers could contribute. The large surface-to-volume ratio 
of nanofibers allows more binding sites for analytes recognition, thus ensures an optimal sensitivity 
of electrospun nanofibers incorporated biosensors. Electrospun nanofibers are typically integrated 
into biosensors through two avenues76. Electrospun functional polymers such as PANi, can be 
directly used as the inducing element in biosensors. The other one is using electrospun nanofibers 
as templates for sensing materials deposition.  
 
Figure 6. Schematic illustration of basic concept of a biosensor. Biorecognition elements such as 
antibodies, enzymes and nucleic acids, are incorporated in the sensing membrane to detect analytes via 
specific binding mechanisms. The transducer will convert acquired signals such as chemical substances, 
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light, heat etc. to electrical signals for further processing and analysis.  
Incorporation of biomolecules to electrospun nanofibers is common for substance recognition. For 
example, glucose oxidase is a glucose sensitive enzyme, which has been widely immobilized on 
electrospun nanofibers for glucose biosensors construction. However, use of enzyme is usually 
associated with instability and denaturation problems. Therefore, several studies investigated non-
enzymatic glucose sensing using carbon, metals and their oxides as electrodes. In one demonstration, 
bimetallic nanoparticles CuCo doped electrospun carbon nanofibers were developed for enzyme-
free glucose detection77. Such glucose biosensor showed a high sensitivity, fast response within 2 s, 
long-term stability and excellent anti-interference to electroactive molecules. 
Electrospun nanofibers incorporating biosensor can be used for early cancer diagnosis. Substances 
to be detected for early cancer diagnosis include specific biomarkers overexpressed by cancer cells, 
oxygen level, circulating tumor cells (CTCs). Specific antibodies, surface functional groups, and 
oxygen sensitive materials can be incorporated to electrospun nanofibers early diagnosis. For 
instance, epidermal growth factor receptor 2 (ErbB2)-antibody was conjugated to mesoporous ZnO 
nanofibers for breast cancer diagnosis78. Combination between electrospun nanofibers with 
microfluidic techniques can improve the diagnostics sensitivity and CTC capture efficiency. A 
microfluidic immunosensor was designed for ErbB2 detection79, which is a breast cancer biomarker. 
The immunoelectrode of this biosensor composed of the porous graphene foam modified with 
electrospun carbon-doped TiO2 nanofibers. This microfluidic biosensor allowed a wide 
concentration range of target ErbB2 antigen and achieved femtomolar sensitivity. CTCs are cancer 
cells that shed from the primary tumor and circulated into the bloodstream leading to metastasis80. 
A microfluidic chip was fabricated for melanoma CTCs capture via conjugation of anti-146 antibody, 
a melanoma-specific capture agent, to PLGA nanofibers 81. This biosensor not only exhibited high 
CTCs capture efficiency, but enabled specific isolation of single circulating melanoma cell.   
Other applications 
Medical device and implant coating 
Electrospun nanofibers can be deposited on medical implants to improve the biocompatibility or 
acquire additional function. Nanofibrous coating would change the implant surface topography, thus 
providing topographical cues to surrounding cells and tissue. Incorporating bioactive agents or even 
cells into nanofibers can achieve multifunctional medical device coating such as drug delivery. 
Palumbo et al. coated biodegradable magnesium prosthesis with a porous PCL layer through 
electrospinning82. Such porous coating could enhance cell adhesion and act as a drug releaser for 
anti-infection. A commercial coronary stent system, PK Papyrus (Biotronik)83, incorporates 
polyurethane as a stent coating for higher bending flexibility. A stent for aneurysm treatment was 
coated with PLCL nanofibers to achieve anti-coagulation and rapid endothelialization84. Heparin 
and vascular endothelial growth factors were encapsulated into the core of PLCL nanofibers. Such 
core-sheath structure allows a sustained release for 30 days without an initial burst release. The 
nanofibrous coating can act as an interphase between the implant and host tissue to minimize the 
stiffness mismatch at the interface, which is quite critical in hard tissue prosthesis failure60.  
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In vitro 3D cancer models 
The in vitro cancer models provide an effective way for drug screening, anti-cancer mechanism, and 
tumor cell biology etc. Traditional 2D cancer models employ culturing tumor cell monolayer on 2D 
flasks, which can reflect cancer cell behavior to a certain degree85. However, tumor cells behave 
differently in 2D models and 3D models. 2D cancer models are difficult to mimic cell-cell and cell-
matrix interactions. Whereas 3D models can offer a comprehensive understanding of the collective 
behavior between cells and cell-matrix, thus allow more accurate control of tumor activities80.  
Electrospun nanofibers mimic the native structure and composition of ECM for target tissue 
regeneration or mimic the stem cell niches for stem cell differentiation. Similarly, to construct an in 
vitro 3D tumor model, electrospun nanofibers play a role in replicating native extracellular 
environment for the tumor cells. Electrospun nanofibers can realize the biochemical stimuli of 
native tumor ECM through surface functionalization with biomolecules or drug encapsulation. For 
instance, perlecan domain IV peptide was conjugated on electrospun PCL/gelatin nanofibers to 
construct a pharmacokinetic prostate cancer model86. Tumor ECM yet exhibit a physiological 
complexity and heterogenous feature80. Currently, electrospun in vitro 3D tumor models encounter 
some challenges including failure in mimicking the tumor angiogenesis, heterotypic cell-cell 
signaling, biomechanical stimuli as well as insufficient cell infiltration. Inclusion of bioreactors in 
model fabrication can provide mechanical stimulus to cancer cells87. Combining electrospinning 
with bioprinting technology may help with more sophisticated 3D cancer models development.  
Filtration membranes for biomedical applications and wearables 
Large surface-to-volume ratio, light weight, high porosity, interconnectivity, and microscale 
interstitial space make electrospun nanofiber meshes an excellent material for filtration applications 
in terms of personal protective equipment. Conventional protective clothing is based on full barrier 
protection that are limited in weight and moisture retention88. Electrospun nanofibers can contribute 
to light-weight and breathable fabrics production that permit air and water vapor transport but filter 
other undesired agents60. Protective masks are typical used filtration membranes in biomedical 
applications. Chemical and biological threats such as nerve agents, bacteria and virus can be blocked 
and even decomposed through active reagents embedded on the nanofibrous membrane. 
Electrospun nonwoven PAN nanofibrous mats incorporated with sliver nanoparticles were used for 
bacterial filtration89. Such filter possessed 99 % bacterial filtration efficiency with promising anti-
bacterial activity. There is supply shortage of face masks during the outbreak of COVID-19. 
Researchers from Korea Advanced Institute of Science and Technology (KAIST) developed 
washable and reusable nanofiber filtered masks to deal with that90. The masks contain electrospun 
orthogonally aligned nanofibers with a diameter of 100-500 nm. Upon 20 repeated bactericidal tests 
with ethanol, masks maintain more than 94 % filtration efficiency and water resistant without 
deformation in the membrane structure. Inovenso Ltd. fabricated nanofiber face masks containing 
non-woven electrospun layers with 99.9 % filtration efficiency91. It is believed that nanofiber masks 
would be the new generation with their small pore size, large surface area and light weight. 
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Conclusion 
We overviewed advances of electrospun nanofibers in biomedical applications and highlighted the 
application in tissue engineering, drug delivery, biosensors and cancer diagnosis. There are various 
types of commercial biomedical products based on electrospun nanofibers (Table 3). 
Electrospinning allows the manipulation of material properties down to the nanoscale, which is the 
most consistent scale to native ECM. Instead of the traditional 2D scaffolds used in those 
applications, 3D scaffolds are more favored for more efficient resemblance to native ECM. A 
complete replication of cell-matrix interactions can enhance the regeneration efficiency. Therefore, 
the influence of nanofibers on cellular signaling mechanisms and biochemical pathways is 
encouraged to further investigate for a better understanding of cell-nanofiber interactions. Drugs 
can be encapsulated into nanofibers through post-electrospinning modifications, blend 
electrospinning as well as coaxial electrospinning, and nanoparticles incorporation. Different drug 
loading methods result in different drug releasing profiles. Drug releasing from nanofibers following 
a predictable spatiotemporal profile is more expected in the future. Whereas there are few studies 
of pharmacokinetics of drug-loaded electrospun nanofibers, which would limit the practical 
application. Overall, the future opportunities would lie in multifunctional electrospun products 
development based on combination of various applications. For example, drug releasing 
nanofibrous scaffolds can simultaneously promote tissue regeneration and achieve therapeutic 
function. Or anti-tumor drug embedded biosensors for early cancer diagnosis and chemotherapy. 
Combining electrospinning with other biofabrication techniques can benefit 3D hierarchical and 
heterogenous structure construction such as cooperation with microfluidic technique for cancer 
biosensors and with bioprinting for 3D cancer models.  
By optimizing properties nanofibrous mats in terms of fiber diameter, orientation, morphology, 
porosity, mechanical properties, electrospun nanofibrous products can be explored for more specific 
requirements of different applications. Melt electrospinning and near-field electrospinning can 
avoid toxic solvents incorporation and high electric field interference, respectively. Inspired by AM, 
direct writing electrospinning allows development of highly customizable 3D constructs with well-
defined features. While those techniques typically generate fibers on micrometer scale, which limits 
their employment in nanometer scale favored applications. Hence, a complete understanding of 
electrospinning mechanisms especially in the fast acceleration zone that contributes to sufficient 
thinning of fibers, will benefit the prediction of fiber properties. Simulation and modelling design 
of such mechanism can help with electrospinning parameters selection prior to the actual 
experiments. There are concerns associated with the environmental effect of organic solvents during 
solution electrospinning. How to achieve a “green” process remains to be addressed. Besides, there 
are difficulties in scale-up production due to the lack of a reliable system for quality control. With 
a comprehensive understanding of the electrospinning mechanism and better control of nanofiber 
properties, further developments of electrospinning in healthcare in following decades can be 
expected. 
Table 3. Examples of commercial electrospun products for healthcare. 
Commercial products Company & 
country 
Stage of products Electrospun 
material 
Application 
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AVflo™ Nicast (Israel) CE certified (2008) PU Nanofibrous 
vascular grafts 
Bioweb™ Zeus (USA) Clinical use PTFE Vascular stent 
coating 
PK Papyrus Biotronik 
(Germany) 
FDA approved 
(Sept. 2018) 
PU PU covered 
coronary stent 
system 
ReBOSSIS ORTHOREBIRTH 
(USA) 
FDA cleared 
(2018) 
β-TCP/PLLA/SiV Bone void filler 
SurgiClot® St Teresa Medical 
(USA) 
Clinical use Dextran Hemostatic wound 
dressing 
ReDura™ MEDPRIN 
(Germany) 
Clinical use PLLA Dural substitute 
patch 
NeoDura™ MEDPRIN 
(Germany) 
Clinical use Synthetic polymers 
/gelatin 
Dural substitute 
patch 
Rivelin® patch Bioinicia (Spain) Clinical trial (phase 
2) 
Drug delivery layer: 
PVP/Eudragit 
RS100® 
Hydrophobic backing 
layer: PCL 
Mucoadhesive drug 
delivery patch 
HealSmart™ personalized 
antimicrobial dressings 
PolyRemedy® 
(USA) 
Clinical use Hyaluronic acid Personalized 
wound-care system 
SpinCare™ Nanomedic 
(Israel) 
CE certified (2017) - A portable bedside 
wound care device  
Stem cell culture/extract 
sheet 
ORTHOREBIRTH 
(USA) 
- Bioresorbable 
polymers 
Stem cell culturing 
for research studies 
BioPaper™ Technology Dipole Materials 
(USA) 
- Various materials 
(e.g. gelatin, colagen) 
Lab tissue culture 
Cytoweb® sheets eSpin (USA) - PLGA, PLA, PCL, 
PU 
In vitro cell culture 
NanoAligned™ Nanofiber 
solutions (USA) 
- PCL 3D cell culture 
Mimetix® Electrospinning 
Company (UK) 
- PLLA Multi-well plates 
for 3D cell culture 
β-TCP: β-tricalcium phosphate; SiV: siloxane-containing calcium carbonate 
Nomenclature 
PCL: poly(ε-caprolactone); PLLA: poly (L-lactic acid); PDLLA: poly (D, L-lactic acid); PLA: poly 
(lactic acid); PLGA: poly(lactic-co-glycolic) acid; PLCL: poly (L-lactide-co-ε-caprolactone); PAN: 
polyacrylonitrile; PANi: polyaniline; PEI: polyethylenimine; PEG: polyethylene glycol, PVA: poly 
(vinyl alcohol); PU: polyurethane; PVP: polyvinylpyrrolidone; PEO: poly (ethylene oxide) 
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